Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

被引:165
|
作者
Belk, Julia A. [1 ,2 ]
Yao, Winnie [3 ]
Ly, Nghi [3 ]
Freitas, Katherine A. [4 ,5 ]
Chen, Yan-Ting [6 ]
Shi, Quanming [3 ]
Valencia, Alfredo M. [7 ,8 ]
Shifrut, Eric [2 ]
Kale, Nupura [9 ]
Yost, Kathryn E. [10 ]
V. Duffy, Connor [11 ]
Daniel, Bence [2 ,3 ]
Hwee, Madeline A. [6 ]
Miao, Zhuang [11 ]
Ashworth, Alan [9 ,12 ]
Mackall, Crystal L. [13 ,14 ,15 ,16 ]
Marson, Alexander [2 ,9 ,12 ,13 ,17 ,18 ,19 ]
Carnevale, Julia [2 ,9 ]
Vardhana, Santosh A. [6 ,13 ]
Satpathy, Ansuman T. [2 ,3 ,4 ,13 ,16 ]
机构
[1] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
[2] Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94158 USA
[3] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Immunol Grad Program, Stanford, CA 94035 USA
[5] Stanford Univ, Sch Med, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA 94035 USA
[6] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[7] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[8] Stanford Univ, Wu Tsai Neurosci Inst, Stanford Brain Organogenesis, Stanford, CA 94305 USA
[9] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA
[10] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA
[11] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[12] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[13] Parker Inst Canc Immunotherapy, San Francisco, CA 94305 USA
[14] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Hematol Oncol Stem Cell Transplant & R, Stanford, CA 94305 USA
[15] Stanford Univ, Dept Pediat, Sch Med, Div BMT & Cell Therapy, Stanford, CA 94305 USA
[16] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[17] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[18] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
[19] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
EPIGENETIC LANDSCAPE; CANCER; DYSFUNCTION; SUBSETS; INTERROGATION; ACCESSIBILITY; INFECTION; DISCOVERY; COOPERATE; STATES;
D O I
10.1016/j.ccell.2022.06.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
T cell exhaustion limits antitumor immunity, but the molecular determinants of this process remain poorly un-derstood. Using a chronic stimulation assay, we performed genome-wide CRISPR-Cas9 screens to system-atically discover regulators of T cell exhaustion, which identified an enrichment of epigenetic factors. In vivo CRISPR screens in murine and human tumor models demonstrated that perturbation of the INO80 and BAF chromatin remodeling complexes improved T cell persistence in tumors. In vivo Perturb-seq revealed distinct transcriptional roles of each complex and that depletion of canonical BAF complex members, including Arid1a, resulted in the maintenance of an effector program and downregulation of exhaustion-related genes in tumor-infiltrating T cells. Finally, Arid1a depletion limited the acquisition of exhaustion-associated chro-matin accessibility and led to improved antitumor immunity. In summary, we provide an atlas of the genetic regulators of T cell exhaustion and demonstrate that modulation of epigenetic state can improve T cell responses in cancer immunotherapy.
引用
收藏
页码:768 / +
页数:27
相关论文
共 50 条
  • [41] The chromatin remodeling landscape of T helper cell differentiation
    Wurster, Andrea
    De, Supriyo
    Precht, Patricia
    Wood, William
    Becker, Kevin
    Pazin, Michael
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [42] A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
    Arek Kendirli
    Clara de la Rosa
    Katrin F. Lämmle
    Klara Eglseer
    Isabel J. Bauer
    Vladyslav Kavaka
    Stephan Winklmeier
    La Zhuo
    Christian Wichmann
    Lisa Ann Gerdes
    Tania Kümpfel
    Klaus Dornmair
    Eduardo Beltrán
    Martin Kerschensteiner
    Naoto Kawakami
    Nature Neuroscience, 2023, 26 : 1713 - 1725
  • [43] A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model
    Kendirli, Arek
    de la Rosa, Clara
    Laemmle, Katrin F.
    Eglseer, Klara
    Bauer, Isabel J.
    Kavaka, Vladyslav
    Winklmeier, Stephan
    Zhuo, La
    Wichmann, Christian
    Gerdes, Lisa Ann
    Kuempfel, Tania
    Dornmair, Klaus
    Beltran, Eduardo
    Kerschensteiner, Martin
    Kawakami, Naoto
    NATURE NEUROSCIENCE, 2023, 26 (10) : 1713 - +
  • [44] Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling
    Barz, T
    Ackermann, K
    Dubois, G
    Eils, R
    Pyerin, W
    JOURNAL OF CELL SCIENCE, 2003, 116 (08) : 1563 - 1577
  • [45] GENOME-WIDE CRISPR SCREENS IN BRAIN TUMOR INITIATING CELLS (BTICS) IDENTIFY POTENT SENSITIZERS OF CONVENTIONAL CHEMORADIOTHERAPY
    Chokshi, Chirayu
    Tieu, David
    Vora, Parvez
    Venugopal, Chitra
    Chan, Katherine
    Tong, Amy
    Brown, Kevin
    Singh, Mohini
    Moffat, Jason
    Singh, Sheila
    NEURO-ONCOLOGY, 2017, 19 : 234 - 235
  • [46] GENOME-WIDE, BIDIRECTIONAL CRISPR SCREENS IDENTIFY MUCINS AS CRITICAL MODULATORS OF SARS-COV-2 INFECTION
    Biering, Scott B.
    Sarnik, Sylvia
    Wang, Eleanor
    Sathyan, Varun
    Nguyenla, Xammy
    Zengel, James
    Van Dis, Erik
    Yamashiro, Livia
    Kim, Jinyoung
    Fox, Douglas
    Carette, Jan
    Stanley, Sarah
    Konermann, Silvana
    Harris, Eva
    Hsu, Patrick
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 151 - 151
  • [47] SINGLE-CELL CRISPR SCREENS IN PRIMARY HUMAN T CELLS IDENTIFY REGULATORS OF TH2 CELL SKEWING
    Loregger, A.
    Irnstorfer, J.
    Untermoser, N.
    Vinko, N.
    Krejci, A.
    Schmidt, H.
    Buerckstuemmer, T.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A43 - A44
  • [48] Single-cell CRISPR screens in primary human T cells identify regulators of Th2 cell skewing
    Loregger, Anke
    Irnstorfer, Johanna
    Untermoser, Nicole
    Vinko, Nikola
    Krejci, Adam
    Schmidt, Henrik
    Burckstummer, Tilmann
    CANCER RESEARCH, 2023, 83 (08)
  • [49] In vivo genome-wide CRISPR/Cas9 screens conducted in an immunocompetent mouse model of glioblastoma identify novel in vivo tumor liabilities and potential mechanisms of resistance to chimeric antigen receptor T-cell (CAR-T) therapy
    Koch, Catherine E.
    Whittaker, Charles A.
    Hemann, Michael T.
    CANCER RESEARCH, 2024, 84 (05)
  • [50] Genome-wide epigenetic alterations in T-cell prolymphocytic leukemia.
    Tian, Shulan
    Zhang, Henan
    Klee, Eric
    Yan, Huihuang
    Ding, Wei
    CANCER RESEARCH, 2021, 81 (13)